Stocks
Arena Pharmaceuticals (ARNA) EBITDA margin US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -379.7% | -724.6% | 64.0% | -124 249% | -1 126 670% | -1 128 657% | ||
| Changes by years, y/y, % | -374pp | -345pp | +789pp | -124 313pp | -1 002 422pp | +1 060.0% | |||
Arena Pharmaceuticals. EBITDA margin, %
Arena Pharmaceuticals. EBITDA margin, changes, pp
Arena Pharmaceuticals (ARNA) EBITDA margin US GAAP (quarter values) |
||||||||
| 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | 2021Q4 | LTM ? | |||
| EBITDA margin, % | ? | -324 611% | -284 539% | -1 128 657% | ||||
| Changes by years, y/y, % | -321 515pp | +39 588pp | +476 700pp | +40 072pp | ||||
| Changes by quarters, q/q, % | +152 089pp | +324 611pp | ||||||
